Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

4 of 6 completed trials have results

Key Signals

1 recruiting4 with results

Enrollment Performance

Analytics

N/A
5(71.4%)
Phase 2
2(28.6%)
7Total
N/A(5)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT03282890Not ApplicableCompleted

Testing an Integrated Bio-Behavioral Primary HIV Prevention Intervention Among High-Risk People Who Use Drugs

Role: collaborator

NCT01741311Not ApplicableCompleted

Secondary HIV Prevention and Adherence Among HIV-infected Drug Users

Role: collaborator

NCT06650267Phase 2Recruiting

Substance Misuse and Family Violence Treatment Fathers

Role: collaborator

NCT03089541Not ApplicableCompleted

Electronic Cigarette Use in Young Adult Men and Women

Role: collaborator

NCT00319241Phase 2Completed

Relational Parenting Group for Opioid-addicted Mothers

Role: collaborator

NCT02124980Not ApplicableCompleted

Automated Recovery Line for Medication Assisted Treatment

Role: collaborator

NCT01741350Not ApplicableCompleted

Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users

Role: collaborator

All 7 trials loaded